https://doi.org/10.55788/075f03cd
Dr Jenna Broman (University of Helsinki, Finland) and colleagues investigated the rate of recurrent strokes, vascular events, cancer, death, and associated factors among patients who experienced an ischaemic stroke or TIA. From the 5,023 patients aged 18 to 55 who experienced an acute cerebrovascular event and were recruited for a previous study [1], 396 patients were evaluated after approximately 10 years of follow-up [2].
In total, 22.5% had experienced a recurrent vascular event, of which 15.7% were cerebrovascular events and 8.6% were classified as āother vascular eventsā. Next, 6.8% of the patients had died (n=27), most frequently due to a vascular event (n=12) or because of cancer (n=7).
Atrial fibrillation at baseline was an independent risk factor for recurrent vascular events in the long term (adjusted HR 3.24; 95% CI 1.26ā8.37). Dr Broman also shared that patients often retained the same cause for the recurrent vascular event as the one that was determined for the first event.
āFurther studies are needed to investigate whether detailed individual risk assessment and more rigorous secondary preventive strategies and patient adherence can reduce the risk of recurrent vascular events,ā reasoned Dr Broman.
- Rolfs A, et al. Stroke. 2013;44(2):340-349.
- Broman J, et al. Long-term risk of recurrent vascular events and mortality in young stroke patients: insights from a multicenter study. Highlights and breaking news, 10th EAN Congress, 29 Juneā2 July 2024, Helsinki, Finland.
Copyright Ā©2024 Medicom Medical Publishers
Posted on
Previous Article
« Anticoagulation or antiplatelet as secondary prevention for cancer-related strokes? Next Article
Changing treatment landscape in myasthenia gravis »
« Anticoagulation or antiplatelet as secondary prevention for cancer-related strokes? Next Article
Changing treatment landscape in myasthenia gravis »
Related Articles
April 14, 2022
Telerobotics may enable remote-controlled stroke surgery
September 9, 2020
Early edoxaban may be safe after cardioembolic stroke
Ā© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com